Localized prostate cancer: use of serial prostate-specific antigen measurements during radiation therapy. 1992

S Vijayakumar, and S F Quadri, and T G Karrison, and C O Trinidad, and S K Chan, and H J Halpern, and S J Rubin, and H G Sutton
Department of Radiation Oncology, Humana Hospital-Michael Reese, Chicago, IL 60616.

The serum half-life of prostate-specific antigen (PSA) after radical prostatectomy is about 3 days; to the authors' knowledge, the PSA half-life during radiation therapy (RT) has not been investigated with weekly serial measurements. To determine the rate of decline and the half-life of PSA, serial measurements were obtained during 6-8 weeks of external-beam RT for localized prostate cancer. PSA values were determined immediately before and approximately 24 hours after the first dose of RT; thereafter, weekly measurements were made. There was a downward trend in PSA levels in 19 patients, with a median half-life of 58.5 days; the mean decline was 1.6% per day. However, in four patients, PSA levels either rose and fell to pre-RT values or increased steadily. The effect of digital rectal examination (DRE) on PSA levels was also analyzed. When the dates of DRE and subsequent PSA levels were inspected, no increase in PSA levels subsequent to DRE was found, although three of the four patients in whom PSA levels did not decrease underwent multiple DREs. The authors found a statistically significant (P = .023) transient elevation in the mean PSA values after the first fraction of RT (2 Gy) was administered; the mechanism and importance of which are not known.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Vijayakumar, and S F Quadri, and T G Karrison, and C O Trinidad, and S K Chan, and H J Halpern, and S J Rubin, and H G Sutton
May 1995, International journal of radiation oncology, biology, physics,
S Vijayakumar, and S F Quadri, and T G Karrison, and C O Trinidad, and S K Chan, and H J Halpern, and S J Rubin, and H G Sutton
September 1994, International journal of radiation oncology, biology, physics,
S Vijayakumar, and S F Quadri, and T G Karrison, and C O Trinidad, and S K Chan, and H J Halpern, and S J Rubin, and H G Sutton
December 2003, Australasian radiology,
S Vijayakumar, and S F Quadri, and T G Karrison, and C O Trinidad, and S K Chan, and H J Halpern, and S J Rubin, and H G Sutton
August 1994, Surgery,
S Vijayakumar, and S F Quadri, and T G Karrison, and C O Trinidad, and S K Chan, and H J Halpern, and S J Rubin, and H G Sutton
January 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S Vijayakumar, and S F Quadri, and T G Karrison, and C O Trinidad, and S K Chan, and H J Halpern, and S J Rubin, and H G Sutton
May 2000, Clinical cancer research : an official journal of the American Association for Cancer Research,
S Vijayakumar, and S F Quadri, and T G Karrison, and C O Trinidad, and S K Chan, and H J Halpern, and S J Rubin, and H G Sutton
December 2003, The Journal of urology,
S Vijayakumar, and S F Quadri, and T G Karrison, and C O Trinidad, and S K Chan, and H J Halpern, and S J Rubin, and H G Sutton
March 2015, Prostate international,
S Vijayakumar, and S F Quadri, and T G Karrison, and C O Trinidad, and S K Chan, and H J Halpern, and S J Rubin, and H G Sutton
May 1995, International journal of radiation oncology, biology, physics,
S Vijayakumar, and S F Quadri, and T G Karrison, and C O Trinidad, and S K Chan, and H J Halpern, and S J Rubin, and H G Sutton
September 2023, Prostate international,
Copied contents to your clipboard!